RxDoctor Payments DataLook up a doctor →

David Rimm

Anatomic Pathology · New Haven, CTNPI 1154303402

Payments from drug & device makers

$3,708,229in general payments, 2019–2025

Across 151 payments — averaging $24,558 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Leica Microsystems Inc.$2.2M
  • Cepheid$521K
  • Amgen$450K
  • AstraZeneca$299K
  • Regeneron$150K
  • Merck$18K
  • plus $33K from 15 others
$1,107,358in research payments, 2019–2025

Across 3 payments — averaging $369,119 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Leica Microsystems Inc.$1.1M

What the payments were for

  • Consulting fees$108,74286%
  • Speaking & faculty fees$6,0005%
  • Travel & lodging$7,1476%
  • Food & beverage$3,9873%
  • Education$4360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,708,229 in reported general payments places this provider in the 95th percentile of 28 anatomic pathology providers in Connecticut.

See all anatomic pathology providers in Connecticut

Other anatomic pathology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →